BMO Capital Raises Price Target for Healthpeak Properties; Morgan Stanley Downgrades to Equal Weight
On June 15, BMO Capital raised its price target for Healthpeak Properties (NYSE:DOC) from $20 to $24 and maintained an Outperform rating. In contrast, on June 11, Morgan Stanley downgraded the stock to Equal Weight from Overweight but increased its price target to $22 from $20.
Topics: Dividend Stocks Real Estate REITs